XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES              
Net income $ 9,044 $ 9,023 $ 10,324 $ 6,599 $ 27,591 $ 25,553  
Adjustments to reconcile net income to net cash provided by operating activities:              
Gain on sales of loans originated for sale         (31) (468)  
Gain on sales of assets held for sale         (337) 0  
Earnings on investment in bank-owned life insurance (473)   (362)   (1,399) (1,052)  
Loss on sales or calls of securities 0   0   739 0  
Loss on equity securities 27   88   22 345 $ 298
Restricted stock compensation expense         317 243  
Depreciation and amortization 825   954   2,559 2,788  
Provision for credit losses and provision for unfunded commitments         300 0  
Net amortization of investment securities premiums         494 988  
Increase in interest receivable         (812) (902)  
Increase (decrease) in interest payable         397 (57)  
Mortgage loans originated for sale         (1,191) (30,365)  
Proceeds from loans originated for sale         1,345 33,026  
Increase in other assets         1,414 (3,348)  
(Increase) decrease in deferred tax expense         (4,436) 1,062  
Increase in other liabilities         5,019 1,660  
Net Cash Provided by Operating Activities         31,991 29,473  
CASH FLOWS FROM INVESTING ACTIVITIES              
Proceeds from calls/maturities of investment securities held to maturity         904 2,505  
Proceeds from calls/maturities of investment securities available for sale         26,375 41,852  
Proceeds from sales of investment securities available for sale         78,624 0  
Proceeds from sale of equity securities         591 0  
Purchase of investment securities available for sale         0 (218,195)  
Purchase of investment securities held to maturity         0 (22,204)  
Purchase of equity securities         0 (35) (206)
(Purchase) redemption of restricted investment in bank stocks         (3,848) 650  
Net increase in loans         (77,486) (60,256)  
Purchase of bank-owned life insurance         0 (12,200)  
Acquisition of insurance books of business/agency         (174) (7,800)  
Capital expenditures (68)   (486)   (174) (1,206)  
Proceeds from sales of premises and equipment         0 1,093  
Proceeds from sales of assets held for sale         3,730 0  
Net Cash Provided by (Used in) Investing Activities         28,542 (275,796)  
CASH FLOWS FROM FINANCING ACTIVITIES              
Net decrease in demand deposits         (29,519) (33,945)  
Net decrease in time certificates of deposits and interest bearing deposits         (218,097) (56,231)  
Net (decrease) increase in short-term borrowings         (8,848) 6,439  
Proceeds from long-term borrowings         100,000 1,500  
Repayments on long-term borrowings         0 (12,150)  
Dividends paid         (7,157) (6,734)  
Common stock repurchased         (1,575) (6,682)  
Common stock issued         543 1,021  
Net Cash Used In Financing Activities         (164,653) (106,782)  
Net Decrease in Cash and Cash Equivalents         (104,120) (353,105)  
CASH AND CASH EQUIVALENTS — BEGINNING   $ 168,161   $ 710,131 168,161 710,131 710,131
CASH AND CASH EQUIVALENTS — ENDING $ 64,041   $ 357,026   64,041 357,026 $ 168,161
Supplemental disclosures of cash flow information:              
Cash paid for interest         3,717 2,834  
Cash paid for income taxes         7,350 4,400  
Supplemental disclosures of certain noncash activities:              
Investments transferred from available for sale to held to maturity         0 39,683  
Premises and equipment transferred to fixed assets held for sale         0 3,393  
Loans transferred to foreclosed assets held for resale and other foreclosed transactions         $ 0 $ 474